This is a paid post contributed by a Patch Community Partner. The views expressed in this post are the author's own, and the information presented has not been verified by Patch.
GLP-1 weight-loss medications can produce significant changes on the scale, but the scale does not show whether weight is coming from fat, lean tissue or water. New research is putting more attention on muscle preservation, body composition and physical activity during treatment. Refresh - Aesthetics & Wellness explains what patients in Jupiter, Wellington and throughout Palm Beach County should know.
Interest in GLP-1 weight loss has moved far beyond a passing trend. Research presented at the 2026 International Congress on Obesity found that internet searches for obesity medications had increased 25-fold over the past decade.
As these medications become more familiar, the questions are becoming more sophisticated. Patients are no longer asking only how much weight they can lose. They are also asking what happens to muscle, whether strength training matters and how a medical weight-loss program should measure progress.
That is an important shift because a bathroom scale can tell you that you lost 20 pounds. It cannot tell you what those 20 pounds were made of.
What Does the Research Say About Muscle Loss?
Weight loss generally includes a combination of fat mass and lean mass. That can occur with medication-assisted weight loss, calorie restriction and other approaches.
A 2026 systematic review and meta-analysis of 20 randomized clinical trials involving 15,782 participants looked specifically at lean-mass changes with incretin-based therapies, including semaglutide and tirzepatide.
The researchers found that lean mass accounted for roughly 25% to 39% of total weight lost, depending on the medication studied. Importantly, the proportion of lean mass lost was broadly comparable to lifestyle-based weight loss in the same analysis.
The study also found something clinically useful: lifestyle programs that included resistance training had the most favorable lean-mass preservation.
In other words, the current evidence is more nuanced than the social-media claim that GLP-1 medications simply "melt muscle." Significant weight loss can involve some loss of lean tissue. The better question is how to preserve as much useful muscle and physical function as reasonably possible while losing excess body fat.
Lean Mass Is Not the Same as Muscle Strength
Another reason this topic is easy to oversimplify is that "lean mass" is not identical to skeletal muscle, and a change in measured lean mass does not automatically mean a patient is becoming weaker.
A prospective study published in 2026 followed adults with obesity treated with semaglutide 2.4 mg. Participants lost significant body weight and fat mass. Lean mass decreased earlier in treatment and then stabilized, while handgrip strength improved by the 12-month assessment.
That does not mean muscle loss should be ignored. It means body composition, muscle quality and physical function need to be interpreted together rather than reducing the discussion to one number.
Why Physical Activity Matters During GLP-1 Treatment
There is another reason clinicians are paying attention. A study presented at ENDO 2026 used wearable-device data from adults with obesity who started GLP-1 receptor agonist therapy. Among the participants with sufficient activity data, average daily steps fell by about 560 steps per day after treatment began, while moderate-to-vigorous activity also decreased.
Weight loss did not automatically make people more active. That matters because patients may be eating less, losing weight quickly and moving less at the same time. Current clinical guidance therefore emphasizes appropriate nutrition and regular physical activity, including resistance exercise when suitable for the individual.
The goal is not to turn every weight-loss patient into a bodybuilder. It is to make sure the treatment plan considers what the patient wants to preserve as well as what they want to lose.
Why Body Composition Can Tell You More Than the Scale
Two patients can each lose 20 pounds and have very different changes in body composition. One may lose a greater proportion of body fat while maintaining more lean tissue. Another may lose a larger amount of lean mass along with fat. A standard scale cannot show that difference.
Body-composition systems such as InBody use bioelectrical impedance analysis to estimate measurements including body fat, skeletal muscle mass, body water and visceral fat. These measurements are estimates and can be affected by hydration, food intake, recent exercise and other factors, so consistency in testing conditions matters.
Used appropriately, body-composition testing can provide additional context during a weight-loss program and help patients and providers look beyond total pounds lost.
What Should Patients Pay Attention to During Medical Weight Loss?
A comprehensive medical weight-loss plan should involve more than receiving medication and checking the scale. Depending on the patient, the conversation may include medical history, medications, laboratory testing when appropriate, nutrition, protein intake, physical activity, treatment tolerance, side effects, body-composition trends and long-term goals.
Patients using GLP-1-based medications should also discuss an appropriate exercise plan with their healthcare provider, particularly if they have medical conditions, mobility limitations or have not exercised regularly. Current expert guidance emphasizes adequate nutrition and structured resistance exercise as important strategies for supporting muscle and bone during significant weight loss.
For patients, the practical takeaway is that rapid weight loss is not the only outcome worth measuring.
Learn about medical weight loss
Medical Weight Loss in Jupiter and Wellington
For patients searching for medical weight loss in Jupiter, Wellington or elsewhere in Palm Beach County, it is reasonable to ask a provider how progress will be evaluated beyond body weight.
Refresh - Aesthetics & Wellness incorporates medical evaluation, laboratory testing when appropriate and InBody body-composition assessment into its wellness and weight-management services.
Refresh serves northern Palm Beach County from its Jupiter office at 775 W. Indiantown Road, Suite 5, Jupiter, FL 33458, and central Palm Beach County from its Wellington office at 10140 Forest Hill Boulevard, Suite 150, Wellington, FL 33414.
Treatment recommendations, prescription medications and monitoring are individualized based on medical evaluation and patient needs.
Questions to Ask Before Starting a GLP-1 Weight-Loss Program
The growing popularity of GLP-1 medications has made medication-assisted weight management more visible to patients. The next step is making the conversation around treatment more complete.
A lower number on the scale can be meaningful. Understanding how the body is changing while that number falls may provide a more complete picture of progress.
This post is an advertorial piece contributed by a Patch Community Partner, a local brand partner. To learn more, click here.
Sign up for free local newsletters and alerts for the
West Palm Beach Patch
Patch.com is the nationwide leader in hyperlocal news.
Visit Patch.com to find your town today.